Skip to main content

Published locations for Phase 2 study shows regimen benefit with dasatinib in Ph+ALL therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 2 study shows regimen benefit with dasatinib in Ph+ALL therapy

User login

  • Reset your password
  • /content/phase-2-study-shows-regimen-benefit-dasatinib-phall-therapy
  • /hematologynews/article/215986/all/phase-2-study-shows-regimen-benefit-dasatinib-phall-therapy
  • /hematology-oncology/article/215986/all/phase-2-study-shows-regimen-benefit-dasatinib-phall-therapy
  • /hematologytimes/article/215986/all/phase-2-study-shows-regimen-benefit-dasatinib-phall-therapy